Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-05-07

Novel antithrombotic agents

Objective



The aim of this project is the identification, production and development of novel anti-thrombotic which may be used with broader efficacy over existing entithrombotic agents. This area is of great industrial/economic/social interest because disorders in the coagulation processes are the main cause of mortality in industrialized countries and because presently commercialized anti-thrombotic suffer of sever limitations for therapeutic applications. This area is also particularly interesting for small-medium size companies because it offers the possibility to present to the market novel products based on novel mechanisms of action. The present project concerns, as first part, the production of pure forms of new hirudins from different origins. Their potential use as anticoagulant agents will also be evaluated. The second part of the program is in line with the objectives of the program "Structural biology - area 6.1.3 structure function relationship" because the discovery and refinement of new biochemical entities with desired functions is the scope of the scientific program.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

You need to log in or register to use this function

Call for proposal

Data not available

Coordinator

INBIOS Srl
EU contribution
No data
Address
Via A. Olivetti 1
80078 Pozzuoli
Italy

See on map

Total cost
No data

Participants (1)